JDK 25 brings powerful new features to Java and JVM developers. Here are seven new or updated features that could convince you to switch. Java continues its fast and feature-packed release schedule, ...

Indonesian auteur Kamila Andini's latest project 'Four Seasons in Java' won two prizes at the inaugural Tokyo Gap-Financing ...

While an argument to re-integrate JavaFX floats in an OpenJDK discussion list, Oracle ponders providing better access to JavaFX from the JDK.

Java is one of the most successful and most dreaded technologies in the computer science world. Let's roast this powerful ...

Dive into the ultimate showdown between a Bedrock Player and a Java Player in this exciting video! Explore the differences, ...

Craig Morgan outlines why comparator clinical trials are useful and provides points to consider to ensure the best outcome. In clinical trials, a comparator drug (defined as ‘an investigational or ...

GitHub launches a new AI-powered application modernization capability designed to simplify and accelerate upgrades and ...

Excavated with colonial labor and shipped to the Netherlands, the famous fossil is being repatriated to Indonesia along with 28,000 other fossils. The skull cap of 'Java Man' was discovered by Eugène ...

Researchers from Standford, Princeton, and Cornell have developed a new benchmark to better evaluate coding abilities of large language models (LLMs). Called CodeClash, the new benchmark pits LLMs ...

Despite randomised clinical trials (RCTs) being the gold standard for drug approval studies, the shift towards precision medicine has increased the use of single-arm trials (SATs). SATs lack results ...

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in China, Akeso and Summit Therapeutics’ ivonescimab has shown it can delay ...

After a series of serendipitous discoveries of pharmacological treatments for mania and depression several decades ago, relatively little progress has been made for novel hypothesis-driven drug ...